A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Dose Efficacy and Safety Study of Staccato Loxapine for Inhalation in Patients With Migraine Headache
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2017
At a glance
- Drugs Loxapine (Primary)
- Indications Migraine
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 03 Mar 2008 Primary endpoint 'Pain relief' has been met.
- 03 Mar 2008 Primary endpoint met; top-line results reported in an Alexza Pharmaceuticals media release.
- 09 Jan 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History